Seeing Is Believing
DNTH is currently covered by 5 analysts with an average price target of $34.02. This is a potential upside of $15.8 (86.72%) from yesterday's end of day stock price of $18.22.
Dianthus Therapeutics's activity chart (see below) currently has 0 price targets and 16 ratings on display. The stock rating distribution of DNTH is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 24.67% with an average time for these price targets to be met of 43.8 days.
Highest price target for DNTH is $56, Lowest price target is $36, average price target is $44.6.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 28-Sep-2023.
Currently out of the existing stock ratings of DNTH, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$21.69 (118.46%)
$40
7 months 5 days ago
(11-Nov-2024)
0/4 (0%)
$12.25 (44.14%)
Buy
$52
$33.69 (184.00%)
$48
7 months 5 days ago
(11-Nov-2024)
0/2 (0%)
$24.25 (87.39%)
Buy
$56
$37.69 (205.84%)
$51
7 months 8 days ago
(08-Nov-2024)
1/3 (33.33%)
$26.94 (92.70%)
132
Buy
$36
$17.69 (96.61%)
$38
10 months 7 days ago
(09-Aug-2024)
2/5 (40%)
$8.5 (30.91%)
45
Buy
$39
$20.69 (113.00%)
$22
1 years 2 months 25 days ago
(22-Mar-2024)
1/2 (50%)
$7.06 (22.10%)
42
What is DNTH (Dianthus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DNTH (Dianthus Therapeutics) with a proven track record?
Which analyst has the current lower performing score on DNTH (Dianthus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?
Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?
Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?